Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiorespiratory decompensation following methylprednisolone administration

K G Lucas1, D L Howrie, C K Phebus

  • 1Department of Pediatrics, Children's Hospital of Pittsburgh.

Pediatric Hematology and Oncology
|July 1, 1993
PubMed
Summary

A child on chemotherapy experienced severe hypotension and shock after receiving ondansetron and high-dose methylprednisolone. This case highlights potential cardiovascular risks associated with rapid corticosteroid administration in pediatric oncology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome.

Bone marrow transplantation·2006
Same author

B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen.

Journal of immunology (Baltimore, Md. : 1950)·2000
Same author

A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.

Human gene therapy·2000
Same author

Adoptive immunotherapy for EBV-associated malignancies.

Cancer treatment and research·2000
Same author

Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.

Blood·1999
Same author

CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.

Cellular immunology·1999

Area of Science:

  • Pediatric Oncology
  • Cardiovascular Pharmacology
  • Clinical Toxicology

Background:

  • Primitive neuroectodermal tumors (PNET) are aggressive central nervous system cancers often treated with multidrug chemotherapy.
  • Chemotherapy regimens frequently include antiemetics like ondansetron and corticosteroids such as methylprednisolone to manage side effects.
  • Cardiovascular adverse events, though rare, can occur during cancer treatment, necessitating careful monitoring.

Observation:

  • A 2-year-old female diagnosed with PNET developed acute hypotension, bradycardia, and shock shortly after intravenous administration of ondansetron and high-dose methylprednisolone.
  • The patient's clinical course was characterized by severe hemodynamic instability requiring intensive management.
  • The event occurred during a standard chemotherapy cycle, suggesting a potential drug-related reaction.

Related Experiment Videos

Findings:

  • The severe cardiovascular reaction, including hypotension and shock, was temporally associated with the administration of ondansetron and high-dose methylprednisolone.
  • While the exact cause remains unclear, an idiosyncratic reaction to the rapid infusion of high-dose adrenal corticosteroids is hypothesized.
  • This event underscores the potential for serious adverse drug reactions in pediatric patients undergoing intensive cancer therapy.

Implications:

  • Close monitoring of pediatric patients receiving high-dose corticosteroid therapy, particularly during chemotherapy, is crucial for early detection of adverse cardiovascular events.
  • Slow administration rates for high-dose corticosteroids like methylprednisolone may mitigate the risk of severe hemodynamic instability.
  • Further investigation into the mechanisms underlying idiosyncratic reactions to corticosteroids in this population is warranted to improve patient safety.